ArticleSignal transduction and targeted therapy2022

Intracellular CYTL1, a novel tumor suppressor, stabilizes NDUFV1 to inhibit metabolic reprogramming in breast cancer.

Wenwen Xue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.